Add this topic to your myFT Digest for news straight to your inbox
Japanese conglomerate makes biggest commitment to UK pharma manufacturing in decades
Prime minister Shinzo Abe had indicated that Avigan could be given go-ahead for use this month
A successful coronavirus treatment may not lead to blockbuster sales
The path to monetising influenza drug Avigan is littered with obstacles
Japanese government holds a stockpile of the medicine for about 2m people
Value of transactions reaches 12-year high with upbeat pace expected in 2020
Investors cheer deal that draws a line under a bruising two-year battle
The company president persuaded his workforce to embrace a more transparent approach
Investors may wonder if duo outsmarted themselves to detriment of all company backers
Japanese company alleges breach of contract and blames Carl Icahn
Japanese group ready to sue US printer and photocopier maker over decision to pull deal
Japanese group left scrambling to salvage deal after activist investor wins challenge
The tactical blunders continue to pile up
Japanese group says US photocopier maker has no legal right to end agreement
US photocopier maker reaches truce with activist investors Icahn and Deason
U-turn sparks fury from activist investors Carl Icahn and Darwin Deason
Activists can seize control when incumbents act egregiously
Part of settlement with activist investors who oppose group’s merger with Fujifilm
Move follows pressure from activist shareholders on $6.1bn Fujifilm deal
The Takeda-Shire deal shows companies are buying overseas assets while they still can
US group’s CEO and board criticised in ruling that marks win for activist investors
International Edition